nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PRKCD—coronary artery disease	0.00634	0.0168	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cross-presentation of soluble exogenous antigens (endosomes)—PSMA6—coronary artery disease	0.00603	0.016	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cross-presentation of soluble exogenous antigens (endosomes)—PSMB5—coronary artery disease	0.00603	0.016	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—CRK—coronary artery disease	0.0059	0.0157	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—ACTB—coronary artery disease	0.00576	0.0153	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—UBE2Z—coronary artery disease	0.00538	0.0143	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—CYBB—coronary artery disease	0.00499	0.0132	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—CAMK2D—coronary artery disease	0.00469	0.0125	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IRF1—coronary artery disease	0.00467	0.0124	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PPM1B—coronary artery disease	0.00452	0.012	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—GBP2—coronary artery disease	0.00452	0.012	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—CRK—coronary artery disease	0.00446	0.0118	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—NEDD4—coronary artery disease	0.00436	0.0116	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—ACTB—coronary artery disease	0.00435	0.0115	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—HLA-E—coronary artery disease	0.00415	0.011	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—PSMB5—coronary artery disease	0.004	0.0106	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—PSMA6—coronary artery disease	0.004	0.0106	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—TAP1—coronary artery disease	0.00389	0.0103	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—CYBA—coronary artery disease	0.00386	0.0102	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—CALR—coronary artery disease	0.00384	0.0102	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—HLA-E—coronary artery disease	0.00369	0.00979	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNGR1—coronary artery disease	0.00362	0.0096	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—VCAM1—coronary artery disease	0.00353	0.00937	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—SOCS1—coronary artery disease	0.00347	0.0092	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—SOCS3—coronary artery disease	0.00342	0.00909	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—ITGAV—coronary artery disease	0.00333	0.00883	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—NEDD4—coronary artery disease	0.00317	0.00841	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—MX1—coronary artery disease	0.00311	0.00825	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PRKCE—coronary artery disease	0.00306	0.00811	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—NEDD4—coronary artery disease	0.00291	0.00773	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—PRKCD—coronary artery disease	0.00281	0.00746	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—UBE2Z—coronary artery disease	0.00266	0.00707	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MAP3K8—coronary artery disease	0.0026	0.00689	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—CD36—coronary artery disease	0.00258	0.00684	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PRKCD—coronary artery disease	0.00247	0.00656	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CANX—coronary artery disease	0.00247	0.00655	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3CA—coronary artery disease	0.00243	0.00645	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNGR1—coronary artery disease	0.00241	0.00641	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—ICAM1—coronary artery disease	0.0024	0.00638	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—C8A—coronary artery disease	0.00236	0.00626	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—GHR—coronary artery disease	0.0023	0.00611	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—CAMK2D—coronary artery disease	0.00229	0.00608	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IRF1—coronary artery disease	0.00228	0.00605	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RAB7A—coronary artery disease	0.00226	0.00601	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD59—coronary artery disease	0.0021	0.00558	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MX1—coronary artery disease	0.00208	0.00551	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—HLA-E—coronary artery disease	0.00203	0.00538	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CYBB—coronary artery disease	0.00199	0.00528	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—TAP1—coronary artery disease	0.00193	0.00511	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—JAK2—coronary artery disease	0.00186	0.00494	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—C8B—coronary artery disease	0.00179	0.00474	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNA2—coronary artery disease	0.00179	0.00474	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—VCAM1—coronary artery disease	0.00172	0.00457	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—TNFRSF14—coronary artery disease	0.00172	0.00455	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—SOCS1—coronary artery disease	0.00169	0.00449	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—C7—coronary artery disease	0.00168	0.00446	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—SOCS3—coronary artery disease	0.00167	0.00444	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—CRK—coronary artery disease	0.00165	0.00438	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—UBE2Z—coronary artery disease	0.00162	0.00429	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—PSMB5—coronary artery disease	0.0016	0.00424	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—PSMA6—coronary artery disease	0.0016	0.00424	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NEDD4—coronary artery disease	0.00157	0.00416	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CYBA—coronary artery disease	0.00154	0.00409	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CALR—coronary artery disease	0.00153	0.00407	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—CAMK2D—coronary artery disease	0.00153	0.00406	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—VASP—coronary artery disease	0.00153	0.00406	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IRF1—coronary artery disease	0.00152	0.00404	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—GBP2—coronary artery disease	0.00148	0.00392	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PPM1B—coronary artery disease	0.00148	0.00392	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—HLA-E—coronary artery disease	0.00147	0.00391	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—TXNIP—coronary artery disease	0.00146	0.00387	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—MAPK1—coronary artery disease	0.00145	0.00384	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1RN—coronary artery disease	0.00142	0.00376	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—MAP3K8—coronary artery disease	0.0014	0.00371	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—PRKCD—coronary artery disease	0.00137	0.00364	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—C8A—coronary artery disease	0.00137	0.00364	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—RAB7A—coronary artery disease	0.00137	0.00364	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTSC—coronary artery disease	0.00137	0.00364	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HSP90B1—coronary artery disease	0.00135	0.00359	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-E—coronary artery disease	0.00135	0.00359	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—ITGAV—coronary artery disease	0.00133	0.00353	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—C1QB—coronary artery disease	0.00129	0.00343	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MEF2A—coronary artery disease	0.00124	0.00329	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—SOCS1—coronary artery disease	0.00123	0.00326	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD59—coronary artery disease	0.00122	0.00325	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CANX—coronary artery disease	0.00122	0.00324	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—SOCS3—coronary artery disease	0.00122	0.00322	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNA2—coronary artery disease	0.00119	0.00316	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—SELL—coronary artery disease	0.00119	0.00316	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—ICAM1—coronary artery disease	0.00117	0.00311	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TAP1—coronary artery disease	0.00117	0.0031	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—VCAM1—coronary artery disease	0.00115	0.00305	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—SOCS1—coronary artery disease	0.00113	0.003	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—NR4A1—coronary artery disease	0.00113	0.00299	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—SOCS3—coronary artery disease	0.00112	0.00296	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—MAPK1—coronary artery disease	0.00109	0.0029	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NR4A1—coronary artery disease	0.00108	0.00287	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—STAT5A—coronary artery disease	0.00108	0.00286	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PPP3R1—coronary artery disease	0.00106	0.00282	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD34—coronary artery disease	0.00106	0.00281	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—C8B—coronary artery disease	0.00104	0.00276	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TNFRSF14—coronary artery disease	0.00104	0.00276	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—CD36—coronary artery disease	0.00103	0.00273	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1A—coronary artery disease	0.00102	0.00271	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL18—coronary artery disease	0.00102	0.0027	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HGF—coronary artery disease	0.00101	0.00269	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—CSF2—coronary artery disease	0.001	0.00266	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAP2K3—coronary artery disease	0.001	0.00266	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CYBB—coronary artery disease	0.000985	0.00262	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—C7—coronary artery disease	0.000979	0.0026	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NEDD4—coronary artery disease	0.000952	0.00253	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—coronary artery disease	0.000949	0.00252	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—VASP—coronary artery disease	0.000928	0.00246	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CRK—coronary artery disease	0.000926	0.00246	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PRKCD—coronary artery disease	0.000917	0.00243	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—JAK2—coronary artery disease	0.00091	0.00241	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ACTB—coronary artery disease	0.000904	0.0024	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IRF1—coronary artery disease	0.000854	0.00227	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CTSB—coronary artery disease	0.00085	0.00225	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAP3K8—coronary artery disease	0.000848	0.00225	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—TXNIP—coronary artery disease	0.000848	0.00225	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTSC—coronary artery disease	0.000832	0.00221	CbGpPWpGaD
Methyl aminolevulinate—Rash—Ticagrelor—coronary artery disease	0.00082	0.00132	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Ticagrelor—coronary artery disease	0.000819	0.00131	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTSB—coronary artery disease	0.000816	0.00216	CbGpPWpGaD
Methyl aminolevulinate—Headache—Ticagrelor—coronary artery disease	0.000815	0.00131	CcSEcCtD
Methyl aminolevulinate—Oedema—Trandolapril—coronary artery disease	0.000815	0.00131	CcSEcCtD
Methyl aminolevulinate—Pain—Eplerenone—coronary artery disease	0.000814	0.00131	CcSEcCtD
Methyl aminolevulinate—Oedema—Enalapril—coronary artery disease	0.000811	0.0013	CcSEcCtD
Methyl aminolevulinate—Infection—Trandolapril—coronary artery disease	0.000809	0.0013	CcSEcCtD
Methyl aminolevulinate—Urticaria—Fenofibrate—coronary artery disease	0.000807	0.0013	CcSEcCtD
Methyl aminolevulinate—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000805	0.00129	CcSEcCtD
Methyl aminolevulinate—Discomfort—Captopril—coronary artery disease	0.000802	0.00129	CcSEcCtD
Methyl aminolevulinate—Oedema—Telmisartan—coronary artery disease	0.0008	0.00128	CcSEcCtD
Methyl aminolevulinate—Fatigue—Simvastatin—coronary artery disease	0.0008	0.00128	CcSEcCtD
Methyl aminolevulinate—Infection—Telmisartan—coronary artery disease	0.000795	0.00128	CcSEcCtD
Methyl aminolevulinate—Pain—Simvastatin—coronary artery disease	0.000794	0.00127	CcSEcCtD
Methyl aminolevulinate—Urticaria—Clopidogrel—coronary artery disease	0.000793	0.00127	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PSMA6—coronary artery disease	0.000792	0.0021	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PSMB5—coronary artery disease	0.000792	0.0021	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—DUSP6—coronary artery disease	0.000791	0.0021	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Gemfibrozil—coronary artery disease	0.000791	0.00127	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HSP90B1—coronary artery disease	0.000789	0.00209	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IFNGR1—coronary artery disease	0.000789	0.00209	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Lovastatin—coronary artery disease	0.000788	0.00126	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Valsartan—coronary artery disease	0.000787	0.00126	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—ICAM1—coronary artery disease	0.000784	0.00208	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6ST—coronary artery disease	0.000784	0.00208	CbGpPWpGaD
Methyl aminolevulinate—Eye disorder—Timolol—coronary artery disease	0.000782	0.00125	CcSEcCtD
Methyl aminolevulinate—Discomfort—Perindopril—coronary artery disease	0.000779	0.00125	CcSEcCtD
Methyl aminolevulinate—Dizziness—Rosuvastatin—coronary artery disease	0.000774	0.00124	CcSEcCtD
Methyl aminolevulinate—Urticaria—Ezetimibe—coronary artery disease	0.000773	0.00124	CcSEcCtD
Methyl aminolevulinate—Nausea—Ticagrelor—coronary artery disease	0.000773	0.00124	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Niacin—coronary artery disease	0.000765	0.00123	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CYBA—coronary artery disease	0.000763	0.00202	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CALR—coronary artery disease	0.00076	0.00202	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HLA-E—coronary artery disease	0.000759	0.00201	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Perindopril—coronary artery disease	0.000756	0.00121	CcSEcCtD
Methyl aminolevulinate—Fatigue—Valsartan—coronary artery disease	0.000756	0.00121	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Pravastatin—coronary artery disease	0.000753	0.00121	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—C1QB—coronary artery disease	0.000752	0.002	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—GHR—coronary artery disease	0.000752	0.002	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000752	0.00121	CcSEcCtD
Methyl aminolevulinate—Fatigue—Olmesartan—coronary artery disease	0.000752	0.00121	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Fenofibrate—coronary artery disease	0.000749	0.0012	CcSEcCtD
Methyl aminolevulinate—Pain—Olmesartan—coronary artery disease	0.000746	0.0012	CcSEcCtD
Methyl aminolevulinate—Erythema—Ramipril—coronary artery disease	0.000745	0.0012	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CANX—coronary artery disease	0.000742	0.00197	CbGpPWpGaD
Methyl aminolevulinate—Rash—Rosuvastatin—coronary artery disease	0.000738	0.00118	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Rosuvastatin—coronary artery disease	0.000737	0.00118	CcSEcCtD
Methyl aminolevulinate—Urticaria—Simvastatin—coronary artery disease	0.000737	0.00118	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Clopidogrel—coronary artery disease	0.000736	0.00118	CcSEcCtD
Methyl aminolevulinate—Headache—Rosuvastatin—coronary artery disease	0.000733	0.00118	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Trandolapril—coronary artery disease	0.000732	0.00117	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HMGB1—coronary artery disease	0.000731	0.00194	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Lovastatin—coronary artery disease	0.000731	0.00117	CcSEcCtD
Methyl aminolevulinate—Discomfort—Losartan—coronary artery disease	0.000731	0.00117	CcSEcCtD
Methyl aminolevulinate—Asthenia—Fenofibrate—coronary artery disease	0.000729	0.00117	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-E—coronary artery disease	0.000729	0.00193	CbGpPWpGaD
Methyl aminolevulinate—Pain—Niacin—coronary artery disease	0.000729	0.00117	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Enalapril—coronary artery disease	0.000729	0.00117	CcSEcCtD
Methyl aminolevulinate—Erythema—Timolol—coronary artery disease	0.000728	0.00117	CcSEcCtD
Methyl aminolevulinate—Fatigue—Pravastatin—coronary artery disease	0.000723	0.00116	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—SELL—coronary artery disease	0.000721	0.00191	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MEF2A—coronary artery disease	0.000721	0.00191	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Fenofibrate—coronary artery disease	0.000719	0.00115	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Telmisartan—coronary artery disease	0.000719	0.00115	CcSEcCtD
Methyl aminolevulinate—Pain—Pravastatin—coronary artery disease	0.000717	0.00115	CcSEcCtD
Methyl aminolevulinate—Rash—Acetylsalicylic acid—coronary artery disease	0.000717	0.00115	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Ezetimibe—coronary artery disease	0.000717	0.00115	CcSEcCtD
Methyl aminolevulinate—Asthenia—Clopidogrel—coronary artery disease	0.000717	0.00115	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000716	0.00115	CcSEcCtD
Methyl aminolevulinate—Asthenia—Lovastatin—coronary artery disease	0.000712	0.00114	CcSEcCtD
Methyl aminolevulinate—Oedema—Losartan—coronary artery disease	0.000709	0.00114	CcSEcCtD
Methyl aminolevulinate—Pruritus—Clopidogrel—coronary artery disease	0.000707	0.00113	CcSEcCtD
Methyl aminolevulinate—Infection—Losartan—coronary artery disease	0.000704	0.00113	CcSEcCtD
Methyl aminolevulinate—Fatigue—Trandolapril—coronary artery disease	0.000702	0.00113	CcSEcCtD
Methyl aminolevulinate—Pruritus—Lovastatin—coronary artery disease	0.000702	0.00113	CcSEcCtD
Methyl aminolevulinate—Fatigue—Enalapril—coronary artery disease	0.0007	0.00112	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6R—coronary artery disease	0.000699	0.00186	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Captopril—coronary artery disease	0.000699	0.00112	CcSEcCtD
Methyl aminolevulinate—Asthenia—Ezetimibe—coronary artery disease	0.000698	0.00112	CcSEcCtD
Methyl aminolevulinate—Urticaria—Valsartan—coronary artery disease	0.000696	0.00112	CcSEcCtD
Methyl aminolevulinate—Nausea—Rosuvastatin—coronary artery disease	0.000695	0.00112	CcSEcCtD
Methyl aminolevulinate—Urticaria—Olmesartan—coronary artery disease	0.000693	0.00111	CcSEcCtD
Methyl aminolevulinate—Fatigue—Telmisartan—coronary artery disease	0.00069	0.00111	CcSEcCtD
Methyl aminolevulinate—Pruritus—Ezetimibe—coronary artery disease	0.000688	0.0011	CcSEcCtD
Methyl aminolevulinate—Pain—Telmisartan—coronary artery disease	0.000684	0.0011	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Simvastatin—coronary artery disease	0.000684	0.0011	CcSEcCtD
Methyl aminolevulinate—Asthenia—Eplerenone—coronary artery disease	0.000683	0.0011	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Perindopril—coronary artery disease	0.000679	0.00109	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MX1—coronary artery disease	0.000678	0.0018	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Niacin—coronary artery disease	0.000677	0.00109	CcSEcCtD
Methyl aminolevulinate—Nausea—Acetylsalicylic acid—coronary artery disease	0.000676	0.00108	CcSEcCtD
Methyl aminolevulinate—Erythema—Lisinopril—coronary artery disease	0.000675	0.00108	CcSEcCtD
Methyl aminolevulinate—Pruritus—Eplerenone—coronary artery disease	0.000674	0.00108	CcSEcCtD
Methyl aminolevulinate—Dizziness—Fenofibrate—coronary artery disease	0.000672	0.00108	CcSEcCtD
Methyl aminolevulinate—Fatigue—Captopril—coronary artery disease	0.000671	0.00108	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IFNA2—coronary artery disease	0.000669	0.00177	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Pravastatin—coronary artery disease	0.000667	0.00107	CcSEcCtD
Methyl aminolevulinate—Asthenia—Simvastatin—coronary artery disease	0.000666	0.00107	CcSEcCtD
Methyl aminolevulinate—Dizziness—Clopidogrel—coronary artery disease	0.00066	0.00106	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Furosemide—coronary artery disease	0.00066	0.00106	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ITGAV—coronary artery disease	0.000658	0.00174	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Simvastatin—coronary artery disease	0.000657	0.00105	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—NR4A1—coronary artery disease	0.000656	0.00174	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Lovastatin—coronary artery disease	0.000656	0.00105	CcSEcCtD
Methyl aminolevulinate—Fatigue—Perindopril—coronary artery disease	0.000651	0.00105	CcSEcCtD
Methyl aminolevulinate—Urticaria—Trandolapril—coronary artery disease	0.000647	0.00104	CcSEcCtD
Methyl aminolevulinate—Pain—Perindopril—coronary artery disease	0.000646	0.00104	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Valsartan—coronary artery disease	0.000646	0.00104	CcSEcCtD
Methyl aminolevulinate—Urticaria—Enalapril—coronary artery disease	0.000645	0.00103	CcSEcCtD
Methyl aminolevulinate—Dizziness—Ezetimibe—coronary artery disease	0.000643	0.00103	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CD34—coronary artery disease	0.000643	0.00171	CbGpPWpGaD
Methyl aminolevulinate—Rash—Fenofibrate—coronary artery disease	0.000641	0.00103	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Fenofibrate—coronary artery disease	0.00064	0.00103	CcSEcCtD
Methyl aminolevulinate—Headache—Fenofibrate—coronary artery disease	0.000637	0.00102	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Losartan—coronary artery disease	0.000636	0.00102	CcSEcCtD
Methyl aminolevulinate—Urticaria—Telmisartan—coronary artery disease	0.000636	0.00102	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PRKCE—coronary artery disease	0.000636	0.00169	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—SOCS1—coronary artery disease	0.000634	0.00168	CbGpPWpGaD
Methyl aminolevulinate—Fatigue—Furosemide—coronary artery disease	0.000633	0.00102	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—S100B—coronary artery disease	0.000632	0.00168	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Eplerenone—coronary artery disease	0.00063	0.00101	CcSEcCtD
Methyl aminolevulinate—Rash—Clopidogrel—coronary artery disease	0.00063	0.00101	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Clopidogrel—coronary artery disease	0.000629	0.00101	CcSEcCtD
Methyl aminolevulinate—Asthenia—Valsartan—coronary artery disease	0.000629	0.00101	CcSEcCtD
Methyl aminolevulinate—Pain—Furosemide—coronary artery disease	0.000628	0.00101	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Niacin—coronary artery disease	0.000628	0.00101	CcSEcCtD
Methyl aminolevulinate—Discomfort—Ramipril—coronary artery disease	0.000626	0.00101	CcSEcCtD
Methyl aminolevulinate—Asthenia—Olmesartan—coronary artery disease	0.000626	0.001	CcSEcCtD
Methyl aminolevulinate—Headache—Clopidogrel—coronary artery disease	0.000626	0.001	CcSEcCtD
Methyl aminolevulinate—Rash—Lovastatin—coronary artery disease	0.000626	0.001	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Lovastatin—coronary artery disease	0.000625	0.001	CcSEcCtD
Methyl aminolevulinate—Headache—Lovastatin—coronary artery disease	0.000622	0.000997	CcSEcCtD
Methyl aminolevulinate—Pruritus—Valsartan—coronary artery disease	0.00062	0.000995	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—VCAM1—coronary artery disease	0.00062	0.00164	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PPP3R1—coronary artery disease	0.000619	0.00164	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KITLG—coronary artery disease	0.000619	0.00164	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Pravastatin—coronary artery disease	0.000618	0.000992	CcSEcCtD
Methyl aminolevulinate—Pruritus—Olmesartan—coronary artery disease	0.000617	0.00099	CcSEcCtD
Methyl aminolevulinate—Dizziness—Simvastatin—coronary artery disease	0.000614	0.000985	CcSEcCtD
Methyl aminolevulinate—Rash—Ezetimibe—coronary artery disease	0.000614	0.000985	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Ezetimibe—coronary artery disease	0.000613	0.000984	CcSEcCtD
Methyl aminolevulinate—Discomfort—Timolol—coronary artery disease	0.000612	0.000983	CcSEcCtD
Methyl aminolevulinate—Asthenia—Niacin—coronary artery disease	0.000611	0.000981	CcSEcCtD
Methyl aminolevulinate—Fatigue—Losartan—coronary artery disease	0.000611	0.000981	CcSEcCtD
Methyl aminolevulinate—Headache—Ezetimibe—coronary artery disease	0.00061	0.000978	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—SOCS1—coronary artery disease	0.000609	0.00162	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Ramipril—coronary artery disease	0.000608	0.000975	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—JAK2—coronary artery disease	0.000608	0.00161	CbGpPWpGaD
Methyl aminolevulinate—Pain—Losartan—coronary artery disease	0.000606	0.000973	CcSEcCtD
Methyl aminolevulinate—Nausea—Fenofibrate—coronary artery disease	0.000604	0.000969	CcSEcCtD
Methyl aminolevulinate—Pruritus—Niacin—coronary artery disease	0.000603	0.000967	CcSEcCtD
Methyl aminolevulinate—Asthenia—Pravastatin—coronary artery disease	0.000602	0.000966	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—SOCS3—coronary artery disease	0.000601	0.0016	CbGpPWpGaD
Methyl aminolevulinate—Rash—Eplerenone—coronary artery disease	0.000601	0.000964	CcSEcCtD
Methyl aminolevulinate—Urticaria—Perindopril—coronary artery disease	0.0006	0.000963	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Trandolapril—coronary artery disease	0.0006	0.000963	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Eplerenone—coronary artery disease	0.0006	0.000963	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Enalapril—coronary artery disease	0.000598	0.000959	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CYBB—coronary artery disease	0.000598	0.00159	CbGpPWpGaD
Methyl aminolevulinate—Headache—Eplerenone—coronary artery disease	0.000597	0.000958	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KITLG—coronary artery disease	0.000594	0.00158	CbGpPWpGaD
Methyl aminolevulinate—Oedema—Timolol—coronary artery disease	0.000594	0.000953	CcSEcCtD
Methyl aminolevulinate—Pruritus—Pravastatin—coronary artery disease	0.000594	0.000953	CcSEcCtD
Methyl aminolevulinate—Nausea—Clopidogrel—coronary artery disease	0.000593	0.000952	CcSEcCtD
Methyl aminolevulinate—Infection—Timolol—coronary artery disease	0.00059	0.000947	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Telmisartan—coronary artery disease	0.00059	0.000946	CcSEcCtD
Methyl aminolevulinate—Nausea—Lovastatin—coronary artery disease	0.000589	0.000946	CcSEcCtD
Methyl aminolevulinate—Rash—Simvastatin—coronary artery disease	0.000585	0.000939	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Simvastatin—coronary artery disease	0.000585	0.000938	CcSEcCtD
Methyl aminolevulinate—Asthenia—Trandolapril—coronary artery disease	0.000585	0.000938	CcSEcCtD
Methyl aminolevulinate—Urticaria—Furosemide—coronary artery disease	0.000584	0.000937	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MAP2K3—coronary artery disease	0.000583	0.00155	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Enalapril—coronary artery disease	0.000582	0.000934	CcSEcCtD
Methyl aminolevulinate—Headache—Simvastatin—coronary artery disease	0.000581	0.000933	CcSEcCtD
Methyl aminolevulinate—Dizziness—Valsartan—coronary artery disease	0.00058	0.00093	CcSEcCtD
Methyl aminolevulinate—Nausea—Ezetimibe—coronary artery disease	0.000578	0.000928	CcSEcCtD
Methyl aminolevulinate—Dizziness—Olmesartan—coronary artery disease	0.000577	0.000926	CcSEcCtD
Methyl aminolevulinate—Pruritus—Trandolapril—coronary artery disease	0.000576	0.000925	CcSEcCtD
Methyl aminolevulinate—Asthenia—Telmisartan—coronary artery disease	0.000574	0.000922	CcSEcCtD
Methyl aminolevulinate—Pruritus—Enalapril—coronary artery disease	0.000574	0.000921	CcSEcCtD
Methyl aminolevulinate—Discomfort—Lisinopril—coronary artery disease	0.000568	0.000912	CcSEcCtD
Methyl aminolevulinate—Pruritus—Telmisartan—coronary artery disease	0.000566	0.000909	CcSEcCtD
Methyl aminolevulinate—Nausea—Eplerenone—coronary artery disease	0.000566	0.000908	CcSEcCtD
Methyl aminolevulinate—Dizziness—Niacin—coronary artery disease	0.000563	0.000904	CcSEcCtD
Methyl aminolevulinate—Urticaria—Losartan—coronary artery disease	0.000563	0.000904	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF1—coronary artery disease	0.000562	0.00149	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Captopril—coronary artery disease	0.000558	0.000896	CcSEcCtD
Methyl aminolevulinate—Dizziness—Pravastatin—coronary artery disease	0.000555	0.00089	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MEF2C—coronary artery disease	0.000553	0.00147	CbGpPWpGaD
Methyl aminolevulinate—Rash—Valsartan—coronary artery disease	0.000553	0.000887	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Valsartan—coronary artery disease	0.000552	0.000886	CcSEcCtD
Methyl aminolevulinate—Nausea—Simvastatin—coronary artery disease	0.000551	0.000885	CcSEcCtD
Methyl aminolevulinate—Oedema—Lisinopril—coronary artery disease	0.000551	0.000885	CcSEcCtD
Methyl aminolevulinate—Pruritus—Captopril—coronary artery disease	0.000551	0.000884	CcSEcCtD
Methyl aminolevulinate—Rash—Olmesartan—coronary artery disease	0.00055	0.000882	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Olmesartan—coronary artery disease	0.000549	0.000882	CcSEcCtD
Methyl aminolevulinate—Headache—Valsartan—coronary artery disease	0.000549	0.000881	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AGER—coronary artery disease	0.000548	0.00146	CbGpPWpGaD
Methyl aminolevulinate—Infection—Lisinopril—coronary artery disease	0.000548	0.000879	CcSEcCtD
Methyl aminolevulinate—Headache—Olmesartan—coronary artery disease	0.000546	0.000877	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD40LG—coronary artery disease	0.000546	0.00145	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Ramipril—coronary artery disease	0.000546	0.000876	CcSEcCtD
Methyl aminolevulinate—Asthenia—Perindopril—coronary artery disease	0.000542	0.00087	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Furosemide—coronary artery disease	0.000541	0.000869	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF1—coronary artery disease	0.00054	0.00143	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CRK—coronary artery disease	0.00054	0.00143	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Trandolapril—coronary artery disease	0.000539	0.000865	CcSEcCtD
Methyl aminolevulinate—Rash—Niacin—coronary artery disease	0.000537	0.000862	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Niacin—coronary artery disease	0.000537	0.000861	CcSEcCtD
Methyl aminolevulinate—Dizziness—Enalapril—coronary artery disease	0.000537	0.000861	CcSEcCtD
Methyl aminolevulinate—Pruritus—Perindopril—coronary artery disease	0.000535	0.000858	CcSEcCtD
Methyl aminolevulinate—Headache—Niacin—coronary artery disease	0.000534	0.000857	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Timolol—coronary artery disease	0.000534	0.000856	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1B—coronary artery disease	0.000532	0.00141	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD36—coronary artery disease	0.00053	0.00141	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Telmisartan—coronary artery disease	0.000529	0.000849	CcSEcCtD
Methyl aminolevulinate—Rash—Pravastatin—coronary artery disease	0.000529	0.000849	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Pravastatin—coronary artery disease	0.000529	0.000848	CcSEcCtD
Methyl aminolevulinate—Asthenia—Furosemide—coronary artery disease	0.000527	0.000846	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ACTB—coronary artery disease	0.000526	0.0014	CbGpPWpGaD
Methyl aminolevulinate—Headache—Pravastatin—coronary artery disease	0.000526	0.000843	CcSEcCtD
Methyl aminolevulinate—Fatigue—Ramipril—coronary artery disease	0.000524	0.000841	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PPP2CA—coronary artery disease	0.000524	0.00139	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Losartan—coronary artery disease	0.000522	0.000838	CcSEcCtD
Methyl aminolevulinate—Nausea—Valsartan—coronary artery disease	0.000521	0.000835	CcSEcCtD
Methyl aminolevulinate—Pruritus—Furosemide—coronary artery disease	0.00052	0.000834	CcSEcCtD
Methyl aminolevulinate—Nausea—Olmesartan—coronary artery disease	0.000518	0.000831	CcSEcCtD
Methyl aminolevulinate—Dizziness—Captopril—coronary artery disease	0.000515	0.000826	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PRKCD—coronary artery disease	0.000514	0.00136	CbGpPWpGaD
Methyl aminolevulinate—Rash—Trandolapril—coronary artery disease	0.000514	0.000824	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Trandolapril—coronary artery disease	0.000513	0.000824	CcSEcCtD
Methyl aminolevulinate—Fatigue—Timolol—coronary artery disease	0.000512	0.000822	CcSEcCtD
Methyl aminolevulinate—Rash—Enalapril—coronary artery disease	0.000512	0.000821	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Enalapril—coronary artery disease	0.000511	0.00082	CcSEcCtD
Methyl aminolevulinate—Headache—Trandolapril—coronary artery disease	0.00051	0.000819	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD36—coronary artery disease	0.000509	0.00135	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Losartan—coronary artery disease	0.000509	0.000816	CcSEcCtD
Methyl aminolevulinate—Headache—Enalapril—coronary artery disease	0.000508	0.000816	CcSEcCtD
Methyl aminolevulinate—Pain—Timolol—coronary artery disease	0.000508	0.000815	CcSEcCtD
Methyl aminolevulinate—Nausea—Niacin—coronary artery disease	0.000506	0.000812	CcSEcCtD
Methyl aminolevulinate—Rash—Telmisartan—coronary artery disease	0.000505	0.00081	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Telmisartan—coronary artery disease	0.000504	0.000809	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PPP2CA—coronary artery disease	0.000503	0.00133	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—C3—coronary artery disease	0.000503	0.00133	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Losartan—coronary artery disease	0.000501	0.000805	CcSEcCtD
Methyl aminolevulinate—Headache—Telmisartan—coronary artery disease	0.000501	0.000805	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CAMK2D—coronary artery disease	0.0005	0.00133	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Perindopril—coronary artery disease	0.0005	0.000802	CcSEcCtD
Methyl aminolevulinate—Nausea—Pravastatin—coronary artery disease	0.000498	0.0008	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IRF1—coronary artery disease	0.000497	0.00132	CbGpPWpGaD
Methyl aminolevulinate—Paraesthesia—Lisinopril—coronary artery disease	0.000495	0.000794	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CTSB—coronary artery disease	0.000495	0.00131	CbGpPWpGaD
Methyl aminolevulinate—Rash—Captopril—coronary artery disease	0.000491	0.000788	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Captopril—coronary artery disease	0.00049	0.000787	CcSEcCtD
Methyl aminolevulinate—Headache—Captopril—coronary artery disease	0.000488	0.000782	CcSEcCtD
Methyl aminolevulinate—Dizziness—Furosemide—coronary artery disease	0.000486	0.00078	CcSEcCtD
Methyl aminolevulinate—Nausea—Trandolapril—coronary artery disease	0.000484	0.000777	CcSEcCtD
Methyl aminolevulinate—Urticaria—Ramipril—coronary artery disease	0.000483	0.000775	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—C3—coronary artery disease	0.000483	0.00128	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Enalapril—coronary artery disease	0.000482	0.000774	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BCL2L1—coronary artery disease	0.000481	0.00128	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PSMA6—coronary artery disease	0.00048	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PSMB5—coronary artery disease	0.00048	0.00127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CRP—coronary artery disease	0.000478	0.00127	CbGpPWpGaD
Methyl aminolevulinate—Rash—Perindopril—coronary artery disease	0.000476	0.000765	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Perindopril—coronary artery disease	0.000476	0.000764	CcSEcCtD
Methyl aminolevulinate—Nausea—Telmisartan—coronary artery disease	0.000475	0.000763	CcSEcCtD
Methyl aminolevulinate—Fatigue—Lisinopril—coronary artery disease	0.000475	0.000763	CcSEcCtD
Methyl aminolevulinate—Headache—Perindopril—coronary artery disease	0.000473	0.00076	CcSEcCtD
Methyl aminolevulinate—Urticaria—Timolol—coronary artery disease	0.000472	0.000757	CcSEcCtD
Methyl aminolevulinate—Pain—Lisinopril—coronary artery disease	0.000471	0.000756	CcSEcCtD
Methyl aminolevulinate—Dizziness—Losartan—coronary artery disease	0.000469	0.000752	CcSEcCtD
Methyl aminolevulinate—Rash—Furosemide—coronary artery disease	0.000463	0.000743	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CYBA—coronary artery disease	0.000463	0.00123	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1RN—coronary artery disease	0.000463	0.00123	CbGpPWpGaD
Methyl aminolevulinate—Dermatitis—Furosemide—coronary artery disease	0.000463	0.000743	CcSEcCtD
Methyl aminolevulinate—Nausea—Captopril—coronary artery disease	0.000462	0.000742	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—CALR—coronary artery disease	0.000461	0.00122	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—DUSP6—coronary artery disease	0.000461	0.00122	CbGpPWpGaD
Methyl aminolevulinate—Headache—Furosemide—coronary artery disease	0.00046	0.000739	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK14—coronary artery disease	0.000455	0.00121	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Perindopril—coronary artery disease	0.000449	0.00072	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Ramipril—coronary artery disease	0.000448	0.000719	CcSEcCtD
Methyl aminolevulinate—Rash—Losartan—coronary artery disease	0.000447	0.000717	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Losartan—coronary artery disease	0.000446	0.000717	CcSEcCtD
Methyl aminolevulinate—Headache—Losartan—coronary artery disease	0.000444	0.000713	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-E—coronary artery disease	0.000442	0.00117	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6ST—coronary artery disease	0.000439	0.00117	CbGpPWpGaD
Methyl aminolevulinate—Urticaria—Lisinopril—coronary artery disease	0.000438	0.000703	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Timolol—coronary artery disease	0.000438	0.000702	CcSEcCtD
Methyl aminolevulinate—Nausea—Furosemide—coronary artery disease	0.000436	0.0007	CcSEcCtD
Methyl aminolevulinate—Asthenia—Ramipril—coronary artery disease	0.000436	0.0007	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—NFKBIA—coronary artery disease	0.000436	0.00116	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Ramipril—coronary artery disease	0.00043	0.00069	CcSEcCtD
Methyl aminolevulinate—Asthenia—Timolol—coronary artery disease	0.000426	0.000684	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—HMGB1—coronary artery disease	0.000426	0.00113	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KIT—coronary artery disease	0.000422	0.00112	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ICAM1—coronary artery disease	0.000422	0.00112	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Losartan—coronary artery disease	0.000421	0.000676	CcSEcCtD
Methyl aminolevulinate—Pruritus—Timolol—coronary artery disease	0.00042	0.000675	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—NFKBIA—coronary artery disease	0.000419	0.00111	CbGpPWpGaD
Methyl aminolevulinate—Hypersensitivity—Lisinopril—coronary artery disease	0.000406	0.000652	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KIT—coronary artery disease	0.000405	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—MAPK1—coronary artery disease	0.000405	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—GSK3B—coronary artery disease	0.000405	0.00108	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CREB1—coronary artery disease	0.000402	0.00107	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Ramipril—coronary artery disease	0.000402	0.000645	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—ITGAV—coronary artery disease	0.000399	0.00106	CbGpPWpGaD
Methyl aminolevulinate—Asthenia—Lisinopril—coronary artery disease	0.000395	0.000635	CcSEcCtD
Methyl aminolevulinate—Dizziness—Timolol—coronary artery disease	0.000393	0.000631	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6R—coronary artery disease	0.000392	0.00104	CbGpPWpGaD
Methyl aminolevulinate—Pruritus—Lisinopril—coronary artery disease	0.00039	0.000626	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—IFNA2—coronary artery disease	0.00039	0.00103	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—GSK3B—coronary artery disease	0.000389	0.00103	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CREB1—coronary artery disease	0.000386	0.00102	CbGpPWpGaD
Methyl aminolevulinate—Rash—Ramipril—coronary artery disease	0.000383	0.000615	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Ramipril—coronary artery disease	0.000383	0.000614	CcSEcCtD
Methyl aminolevulinate—Headache—Ramipril—coronary artery disease	0.000381	0.000611	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—VCAM1—coronary artery disease	0.000376	0.000998	CbGpPWpGaD
Methyl aminolevulinate—Rash—Timolol—coronary artery disease	0.000375	0.000601	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Timolol—coronary artery disease	0.000374	0.000601	CcSEcCtD
Methyl aminolevulinate—Headache—Timolol—coronary artery disease	0.000372	0.000597	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—PRKCE—coronary artery disease	0.00037	0.000982	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SOCS1—coronary artery disease	0.000369	0.00098	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—S100B—coronary artery disease	0.000368	0.000977	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—SOCS3—coronary artery disease	0.000365	0.000968	CbGpPWpGaD
Methyl aminolevulinate—Dizziness—Lisinopril—coronary artery disease	0.000364	0.000585	CcSEcCtD
Methyl aminolevulinate—Nausea—Ramipril—coronary artery disease	0.000361	0.000579	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—KITLG—coronary artery disease	0.00036	0.000956	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF2—coronary artery disease	0.000355	0.000943	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Timolol—coronary artery disease	0.000353	0.000566	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—STAT5A—coronary artery disease	0.000352	0.000935	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CA—coronary artery disease	0.000352	0.000933	CbGpPWpGaD
Methyl aminolevulinate—Rash—Lisinopril—coronary artery disease	0.000348	0.000558	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Lisinopril—coronary artery disease	0.000347	0.000557	CcSEcCtD
Methyl aminolevulinate—Headache—Lisinopril—coronary artery disease	0.000345	0.000554	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF2—coronary artery disease	0.000341	0.000906	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—JAK2—coronary artery disease	0.000341	0.000904	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BCL2—coronary artery disease	0.000337	0.000896	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1A—coronary artery disease	0.000333	0.000884	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL18—coronary artery disease	0.000332	0.000882	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HGF—coronary artery disease	0.000331	0.000879	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD40LG—coronary artery disease	0.000331	0.000879	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGF1—coronary artery disease	0.000328	0.000869	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CSF2—coronary artery disease	0.000328	0.000869	CbGpPWpGaD
Methyl aminolevulinate—Nausea—Lisinopril—coronary artery disease	0.000327	0.000525	CcSEcCtD
Methyl aminolevulinate—FCGR1A—Immune System—MEF2C—coronary artery disease	0.000322	0.000855	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AGER—coronary artery disease	0.000319	0.000848	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL6—coronary artery disease	0.000311	0.000826	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD36—coronary artery disease	0.000309	0.00082	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PPP2CA—coronary artery disease	0.000305	0.000809	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PRKCD—coronary artery disease	0.0003	0.000795	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—C3—coronary artery disease	0.000293	0.000777	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL2L1—coronary artery disease	0.00028	0.000744	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CRP—coronary artery disease	0.000278	0.000739	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK14—coronary artery disease	0.000265	0.000704	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6ST—coronary artery disease	0.000256	0.000679	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ICAM1—coronary artery disease	0.000256	0.000679	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—NFKBIA—coronary artery disease	0.000254	0.000674	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—KIT—coronary artery disease	0.000246	0.000653	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—GSK3B—coronary artery disease	0.000236	0.000626	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CREB1—coronary artery disease	0.000234	0.000621	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6R—coronary artery disease	0.000228	0.000606	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MAPK1—coronary artery disease	0.000227	0.000603	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGF2—coronary artery disease	0.000207	0.000549	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—JAK2—coronary artery disease	0.000198	0.000527	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CA—coronary artery disease	0.000197	0.000523	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL2—coronary artery disease	0.000197	0.000522	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CA—coronary artery disease	0.000189	0.000503	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IL6—coronary artery disease	0.000175	0.000463	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1B—coronary artery disease	0.000174	0.000461	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AKT1—coronary artery disease	0.000161	0.000428	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—AKT1—coronary artery disease	0.000155	0.000411	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MAPK1—coronary artery disease	0.000132	0.000351	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CA—coronary artery disease	0.000115	0.000305	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL6—coronary artery disease	0.000102	0.00027	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AKT1—coronary artery disease	9.39e-05	0.000249	CbGpPWpGaD
